We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+10.83%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$366M
AUM Growth
+$30.5M
Cap. Flow
-$2.1M
Cap. Flow %
-0.57%
Top 10 Hldgs %
28.66%
Holding
113
New
5
Increased
29
Reduced
34
Closed
1

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$980K
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$628K
3
T icon
AT&T
T
+$566K
4
AAPL icon
Apple
AAPL
+$417K
5
WU icon
Western Union
WU
+$251K

Sector Composition

Rank Sector Weight
1 Technology 15.04%
2 Healthcare 13.93%
3 Industrials 11.85%
4 Consumer Staples 10.75%
5 Consumer Discretionary 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CL icon
26
Colgate-Palmolive
CL
$73.1B
$5.34M 1.46%
62,543
+465
+0.7% +$36.3K
CMCSA icon
27
Comcast
CMCSA
$85B
$5.29M 1.44%
105,127
-125
-0.1% -$6.51K
DIS icon
28
Walt Disney
DIS
$167B
$4.99M 1.36%
32,248
-530
-2% -$85.6K
MRK icon
29
Merck
MRK
$322B
$4.83M 1.32%
63,074
+105
+0.2% +$8.36K
KO icon
30
Coca-Cola
KO
$377B
$4.78M 1.31%
80,801
+920
+1% +$51.2K
IEFA icon
31
iShares Core MSCI EAFE ETF
IEFA
$190B
$4.78M 1.31%
64,046
+347
+0.5% +$26.1K
NEE icon
32
NextEra Energy
NEE
$181B
$4.77M 1.3%
51,071
+310
+0.6% +$26.8K
IWM icon
33
iShares Russell 2000 ETF
IWM
$79.8B
$4.68M 1.28%
21,039
-310
-1% -$70K
MDT icon
34
Medtronic
MDT
$109B
$4.65M 1.27%
44,978
-1,020
-2% -$118K
INTC icon
35
Intel
INTC
$455B
$4.6M 1.25%
89,250
-2,795
-3% -$143K
VZ icon
36
Verizon
VZ
$195B
$4.24M 1.16%
81,512
-4,540
-5% -$237K
TMO icon
37
Thermo Fisher Scientific
TMO
$213B
$4.18M 1.14%
6,261
DUK icon
38
Duke Energy
DUK
$97.8B
$4.07M 1.11%
38,779
+685
+2% +$69.4K
BNY
39
Bank of New York Mellon
BNY
$106B
$4.06M 1.11%
69,913
-205
-0.3% -$11.8K
JPM icon
40
JPMorgan Chase
JPM
$935B
$3.94M 1.07%
24,858
+15
+0.1% +$2.46K
DHI icon
41
D.R. Horton
DHI
$40B
$3.92M 1.07%
36,145
+405
+1% +$39K
HD icon
42
Home Depot
HD
$331B
$3.88M 1.06%
9,350
LMT icon
43
Lockheed Martin
LMT
$134B
$3.64M 0.99%
10,241
+668
+7% +$231K
SNA icon
44
Snap-on
SNA
$21.2B
$3.54M 0.97%
16,462
+85
+0.5% +$18.2K
OMC icon
45
Omnicom Group
OMC
$21.6B
$3.53M 0.96%
48,185
+175
+0.4% +$12.4K
SPY icon
46
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$3.4M 0.93%
7,148
-70
-1% -$32.1K
AMZN icon
47
Amazon
AMZN
$2.92T
$3.04M 0.83%
18,260
+240
+1% +$41.1K
VTI icon
48
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
$2.99M 0.82%
12,380
XOM icon
49
ExxonMobil
XOM
$644B
$2.91M 0.79%
47,515
XLE icon
50
State Street Energy Select Sector SPDR ETF
XLE
$39.6B
$2.87M 0.78%
103,390

Similar funds

Boston Research & Management's Q4 2021 Portfolio in Review

As of Q4 2021, Boston Research & Management held 113 positions worth $366M, up 9.1% from $336M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Boston Research & Management's Q4 2021 filing shows 5 new, 29 increased, 34 reduced and 1 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 2,684 shares worth $287K. The largest sale was Microsoft, an estimated $980K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

  • Boston Research & Management's largest Q4 2021 buy was iShares Core S&P Total US Stock Market ETF: 2,684 shares worth $287K.
  • Boston Research & Management added most to Magna International in Q4 2021, an estimated $326K increase.
  • Boston Research & Management's biggest Q4 2021 reduction was Microsoft, cutting an estimated $980K.
  • Boston Research & Management fully exited Texas Instruments in Q4 2021, selling an estimated $203K.
  • Boston Research & Management's ten largest holdings make up 29% of its $366M portfolio in Q4 2021.
  • Boston Research & Management opened 5 new positions and closed 1 in Q4 2021.
  • Boston Research & Management's portfolio value rose 9.1% quarter-over-quarter to $366M.

Based on Boston Research & Management's 13F filing for Q4 2021, filed 10 Feb 2022.